Literature DB >> 8640357

Enhancement by cyclo-oxygenase inhibitors of platelet-activating factor production in thapsigargin-stimulated macrophages.

M Watanabe1, M Yamada, S Mue, K Ohuchi.   

Abstract

1. Thapsigargin stimulated the accumulation of cell-associated platelet-activating factor (PAF) and extracellular prostaglandin E2 (PGE2) in rat peritoneal macrophages. PAF in the conditioned medium was less than the detectable amount. To obtain further insight into the mechanism of PAF accumulation, the role of PGE2 in PAF accumulation was investigated. 2. When macrophages were incubated in medium containing thapsigargin (30 ng ml(-1), 46.1 nM) and cyclo-oxygenase inhibitors such as indomethacin, naproxen or ibuprofen, the PAF content of the cells at 10 min was increased in a concentration-dependent manner in accordance with inhibition of PGE2 production. The stimulation by thapsigargin, cyclo-oxygenase inhibitors did not increase PAF accumulation. 3. In thapsigargin-stimulated macrophages, when PGE2(10(-7) M) was added to the medium, the cyclo-oxygenase inhibitor-induced stimulation of PAF accumulation at 10 min was markedly inhibited. 4. The accumulation of PAF induced by thapsigargin alone at 10 min was inhibited by exogenous PGE2 (10(-8) and 10(-7) M), or arachidonic acid (10(-6) and 10(-5) M) in accordance with the increase in PGE2 production. 5. The accumulation of PAF induced by thapsigargin alone or by thapsigargin and indomethacin (10(-6) M) was inhibited by dibutyryl cyclic AMP. 6. These results indicate that the concurrently produced PGE2 in thapsigargin-stimulated macrophages down-regulates PAF accumulation by increasing intracellular cyclic AMP levels, and that cyclo-oxygenase inhibitors increase PAF accumulation by inhibiting PGE2 production.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8640357      PMCID: PMC1908933          DOI: 10.1111/j.1476-5381.1995.tb16423.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

1.  Release of cyclic AMP from macrophages by stimulation with prostaglandins.

Authors:  D Gemsa; L Steggemann; J Menzel; G Till
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

2.  Activation of rabbit platelets by platelet-activating factor derived from IgE-sensitized basophils. Characteristics of the aggregation and its dissociation from secretion.

Authors:  P M Henson
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

3.  Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes.

Authors:  F Malavasi; C Tetta; A Funaro; G Bellone; E Ferrero; A C Franzone; P Dellabona; R Rusci; L Matera; G Camussi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  Synergistic stimulation of histamine release from rat peritoneal mast cells by 12-O-tetradecanoylphorbol 13-acetate (TPA)-type and non-TPA-type tumor promoters.

Authors:  K Ohuchi; N Hirasawa; C Takahashi; M Watanabe; S Tsurufuji; H Fujiki; M Suganuma; H Hakii; T Sugimura; S B Christensen
Journal:  Biochim Biophys Acta       Date:  1986-06-16

5.  Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis.

Authors:  H Hakii; H Fujiki; M Suganuma; M Nakayasu; T Tahira; T Sugimura; P J Scheuer; S B Christensen
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

6.  Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils.

Authors:  J Benveniste
Journal:  Nature       Date:  1974-06-07       Impact factor: 49.962

7.  Thapsigargine and thapsigargicine, two new histamine liberators from Thapsia garganica L.

Authors:  U Rasmussen; S Brøogger Christensen; F Sandberg
Journal:  Acta Pharm Suec       Date:  1978

8.  The ability of thapsigargin and thapsigargicin to activate cells involved in the inflammatory response.

Authors:  H Ali; S B Christensen; J C Foreman; F L Pearce; W Piotrowski; O Thastrup
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

9.  Stimulation of prostaglandin E2 production by 12-O-tetradecanoylphorbol 13-acetate (TPA)-type and non-TPA-type tumor promoters in macrophages and its inhibition by cycloheximide.

Authors:  K Ohuchi; M Watanabe; K Yoshizawa; S Tsurufuji; H Fujiki; M Suganuma; T Sugimura; L Levine
Journal:  Biochim Biophys Acta       Date:  1985-03-27

10.  Activation of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. II. The role of serine proteases, cyclic nucleotides, and contractile elements in PAF-induced secretion.

Authors:  P M Henson; Z G Oades
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

View more
  2 in total

Review 1.  The mechanisms of action of NSAIDs in analgesia.

Authors:  J N Cashman
Journal:  Drugs       Date:  1996       Impact factor: 9.546

2.  Participation of mitogen-activated protein kinase in thapsigargin- and TPA-induced histamine production in murine macrophage RAW 264.7 cells.

Authors:  M Shiraishi; N Hirasawa; Y Kobayashi; S Oikawa; A Murakami; K Ohuchi
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.